Loading...

XML

Word

Printable

JSON

Details

Type: Change Request
Resolution: Persuasive with Modification
Priority: Highest

Specification:

FHIR Core (FHIR)
Raised in Version:

R4
Work Group:

Biomedical Research & Regulation
Related Artifact(s):

PackagedProductDefinition
Grouping:
- MedDef
- block-vote-1
Resolution Description:

Hide

Agree that reference needs to be changed. Also note that there may be other similar cases to be dealt with. The following issues are relevant: 31782, 31859, and 31862

Show
Agree that reference needs to be changed. Also note that there may be other similar cases to be dealt with. The following issues are relevant: 31782, 31859, and 31862
Resolution Vote:
Rik Smithies /Norman Gregory: 10-0-0
Change Category:
Correction
Change Impact:
Non-substantive
Pre Applied:
Yes
Applied for Version:

R5

Description

In FHIR, the new points to the old and the many points to the few. Both of these rules mean that the MarketingAuthorization should point to the packegedproduct, not the other way around. And in fact, it does. Bi-directional references are generally prohibited in FHIR.

Proposed Wording:

lloyd@lmckenzie.com

(Comment 17 - imported by: Ron G. Parker)

Attachments

Issue Links

is voted on by

BALLOT-16109 Negative - Ron G. Parker : 2021-May-FHIR R4B STU

Closed

relates to

FHIR-31782 MedicinalProductDefinition and AdministrableProductDefinition relationship is bi-directional

Published

FHIR-31859 MedicinalProductDefinition can't point to PackagedProductDefinition

Published

FHIR-31862 operation can't point to an authorization

Published

Activity

People

Assignee:: Unassigned

Reporter:: Ron G. Parker

Request in-person:: Lloyd McKenzie, Ron G. Parker

Watchers:: 5 Start watching this issue

Dates

Created:: 2021-04-13 12:02

Updated:: 2023-05-12 04:48

Resolved:: 2021-08-03 08:47

Vote Date:: 2022-03-03